课题基金 / 基金详情

Project 2

Project 2
项目2
批准号:
10625519
负责人:
Sally E Wenzel
金额:
$53.67万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-06-01 至 2027-04-30

项目摘要

项目成果

Sally E Wenzel的其他基金

相似基金

相关文献

中文摘要
翻译
项目2探索了范式转换假设,即上皮处于两个细胞的中心 严重哮喘(SA)的分子表型截然不同。第一,支气管炎 上皮细胞(BEC)S对初始环境刺激做出反应以驱动一种与生俱来的内在 表型。在第二阶段,BEC细胞死亡途径与CD8 T细胞免疫过程相交,从而 驱动一种免疫互动表型。这一假设是基于已发表、提交和 项目1和项目2的初步数据确定了两种免疫细胞表型 严重哮喘,一种不依赖T细胞,另一种与T细胞高度相关,尤其是 CD8细胞。两者都存在相似水平的2型(T2)生物标志物/基因。在出版中 来自上一个周期的数据,上皮生长和修复模块与 哮喘的严重程度高于T2模块,这表明T2免疫本身并不能驱动严重程度。 与基因表达一致的是,体外培养的哮喘BECs创面修复不良, 伴随着增殖能力的丧失。束缚粘蛋白MUC4b在哮喘时增加, 降低BEC的增殖,同时增加分泌。BEC基因聚类反映了项目1与 T细胞和非T细胞相关的SA表型,每种都有相似水平的T2生物标志物。这个 先天固有/非T细胞SA簇与先天核因子-kB和细胞凋亡途径相关 可能通过Toll样受体S。免疫互动/CD8簇相关 IL-12和IL-18、干扰素与炎症小体和下垂途径的上调 通过17q12-21基因,GSDMB。因此,BEC遗传/表观遗传风险之间的相互作用, 先天和获得性免疫以及细胞死亡途径可能对这些不同的 表型,有不同的治疗反应。使用scRNAseq的尖端技术, 先进的生物信息学和机械学的体外和体内模型,我们将完善分子 在第一个周期中确定的表型,并将它们与项目1中确定的细胞图谱联系起来。我们 提出3个目标:1)确定先天固有的机制和功能含义 用新鲜和培养的健康和哮喘BECs进行上皮表型的研究2)评价其作用 GSDMB在IL-18/CD8相关免疫交互表型形成中的作用 利用新鲜和培养的健康和哮喘BECs整合其功能意义 免疫-炎症表型和上皮分子表型,作为倒数第二项努力 将细胞类型、机制和隔间联系起来,严格提炼表型。这些研究 将提高对与细胞死亡相关的分子表型的理解,允许 确定新的精确治疗靶点,以最终确定潜在的内型。
英文摘要
Project 2 explores the paradigm-shifting hypothesis that the epithelium is at the heart of two fundamentally different molecular phenotypes of severe asthma (SA). In the 1st, bronchial epithelial cells (BEC)s respond to initial environmental stimuli to drive an innate intrinsic phenotype. In the 2nd, BEC cell death pathways intersect with CD8 T-cell immune processes to drive an immune interactive phenotype. This hypothesis is based on published, submitted and preliminary data across Project 1 and Project 2 which identify two immune cell phenotypes of severe asthma, one independent of T-cells and another, highly associated with them, in particular with CD8 cells. Similar levels of Type-2 (T2) biomarkers/genes are present in both. In published data from the previous cycle, epithelial growth and repair modules more strongly associated with asthma severity than T2 modules, suggesting T2 immunity alone does not drive severity. Consistent with gene expression, poor wound repair of asthmatic BECs in vitro was reported, with associated loss of a proliferative capacity. The tethered mucin MUC4b, increased in asthma, lowers BEC proliferation, while increasing secretion. BEC gene clustering mirrors Project 1 with T-cell- and non-T-cell associated SA phenotypes, each with similar levels of T2 biomarkers. The innate intrinsic/Non-T-cell SA cluster associates with innate NF-kB and apoptotic pathways potentially through Toll like receptors (TLR)s. The immune interactive/CD8 cluster associates with IL-12 and -18, interferons and upregulation of inflammasome and pyroptosis pathways through the 17q12-21 gene, GSDMB. Thus, interactions between BEC genetic/epigenetic risks, innate and adaptive immunity and cell death pathways may contribute to these distinct phenotypes, with differing treatment responses. Using cutting edge technologies of scRNAseq, advanced bioinformatics and mechanistic in vitro and in vivo models, we will refine the molecular phenotypes identified in the 1st cycle and link them with cell profiles identified in Project 1. We propose 3 aims: 1) Identify the mechanisms for and functional implications of an innate intrinsic epithelial phenotype using fresh and cultured healthy and asthmatic BECs 2) Evaluate the role of GSDMB in the development of a IL-18/CD8-associated immune interactive phenotype and its functional implications using fresh and cultured healthy and asthmatic BECs 3) Integrate immune-inflammatory phenotypes with epithelial molecular phenotypes, as the penultimate effort to link cell types, mechanisms and compartments to rigorously refine phenotypes. These studies will improve the understanding of molecular phenotypes in relation to cell death, allowing Identification of novel precision therapeutic targets to eventually confirm underlying endotypes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Type-2 or Not Type-2: That is the (Therapeutic) Question
Type-2 or Not Type-2: That is the (Therapeutic) Question
Type-2 or Not Type-2: That is the (Therapeutic) Question
Type-2 or Not Type-2: That is the (Therapeutic) Question
国内基金
海外基金
17q21区域内发育性髋关节脱位易感基因的克隆、鉴定及功能研究
  • 批准号:
    30600654
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    22.0万元
  • 批准年份:
    2006
  • 负责人:
    李连永
  • 依托单位: